Neuroinvasive astrovirus (VA1-HMO-C) is an emerging life-threatening infection in immunocompromised hosts. We describe an 8-month-old child who died of VA1/HMO-C encephalitis following bone marrow transplantation. The diagnosis was only made post-mortem using RNA deep sequencing of the brain. Repeat analysis of the post-mortem brain tissue using PCR specific primers for VA1/HMO-C was positive. Astrovirus VA1/HMO-C should be included in the evaluation of patients with similar encephalitis.
Introduction
Encephalitis in immunocompromised patients is a diagnostic challenge as the aetiology of the global brain dysfunction varies depending on the timing, nature and intensity of immunosuppression.
The classical clinical features, laboratory findings and cerebrospinal fluid (CSF) pleocytosis may be lacking in these patients. (1). Moreover, encephalitis remains unexplained in up to 60% of patients despite a comprehensive list of microbiological evaluation with cultures and molecular techniques using real time polymerase chain reaction (PCR) for viruses, bacteria, parasites and fungi. (2, 3) Deep sequencing can be used as a non-selective method for pathogen discovery and has been increasingly used as a diagnostic tool to investigate causes of encephalitis in immunocompromised patients. Sequencing of mRNA is one such approach and is widely used in transcriptome analysis but can also be used to detect mRNA from microorganisms. This technique involves the isolation of messenger RNA from a clinical sample which following amplification of synthesised cDNA. The messenger RNA is analysed using next generation sequencing technology that allows for unbiased and sensitive identification of transcripts present. Subsequent bioinformatic analysis enables the subtraction of human transcripts present and remaining sequences investigated by searching nucleotide sequence databases for homology to identify a potential pathogen. The advantages of this RNA sequencing are 1) no prior knowledge about the type of pathogen is required 2) a sequence is generated for each fragment of cDNA thus allowing identification of mixed populations 3) RNA sequencing enables us to identify RNA viruses and RNA transcripts of bacteria, fungi and DNA viruses.
Here, we describe an 8-month-old child who died of fatal astrovirus (VA1/HMO-C) encephalitis following a haematopoietic stem cell transplant for acute myeloid leukaemia (AML) with high-risk cytogenetics, t (10;11) in first remission. The diagnosis of neuroinvasive astrovirus was made on deep sequencing of her post-mortem brain biopsy.
Case report
The child presented with pancytopenia and hepatosplenomegaly at age of 4 months. The diagnosis of acute myeloid leukaemia was based on marrow studies, which indicated chromosomal translocation 10 and 11. She achieved remission which was consolidated using standard chemotherapy schedules including fludarabine, a nucleoside analogue associated with T-cell immune suppression. The treatment was complicated by Enterobacter neutropenic fevers and enteritis due to human astrovirus (HAsV) infection, followed by persistent asymptomatic astrovirus detection in her stools. Since t(10;11) is associated with a high risk of disease relapse, she had a fully HLA-matched unrelated donor bone marrow transplant in first remission at 8 months old. She was conditioned with busulfan (dose was adjusted to target area under curve (AUC) at 80mg/L/h), cyclophosphamide (120mg/kg), melphalan (140mg/m 2 ) and alemtuzumab (1m/kg over 5 days) and received ciclosporin alone for post-transplant graft-versus-host prophylaxis. The total nucleated cell dose and CD34 cell dose were 2.16 x 10 8 /kg and 5.6 x 10 6 /kg respectively. Neutrophil engraftment was demonstrated on Day +17 and donor chimerism was 100%. Early transplant course was complicated by severe mucositis, culture negative neutropenic fevers, veno-occlussive disease and grade 1 cutaneous graftversus-host disease that responded to topical steroid. Nutrition rehabilitation was complicated by protracted human astrovirus positive diarrhoea, which was finally resolved upon discharge home on In conclusion, our patient had two astrovirus infections, the first one being classical human astrovirus gastroenteritis while the second one due to a VA1/HMO-C encephalitis. Our patient and reported cases illustrate the value of including testing for astrovirus VA1/HMO-C in the diagnosis of encephalitides in immunosuppressed patients. We suggest that deep sequencing should be performed promptly for patients with unexplained encephalopathy as the result is available within 6 days, allowing institution of specific therapy with intravenous immunoglobulin, antiviral therapy and withdrawal of immunosuppressive therapy, which potentially augment the outcome of the patients. 
